Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Asian Pac J Cancer Prev ; 21(11): 3441-3447, 2020 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-33247707

RESUMO

BACKGROUNDS: In breast cancer, blocking of Ras signaling and inhibition of H-Ras is quite promising. H-Ras may become a target for farnesyl transferase inhibitors, and in combination with other immunohistochemical factors it will contribute to the progression of a breast tumor. PURPOSE: The aim of this study was to evaluate the effectiveness of neoadjuvant therapy for breast cancer with the inclusion of farnesyl transferase inhibitor, arglabin interfering with the expression and concentration of H-Ras oncoproteins. METHODS: Depending on the presence of H-Ras oncoproteins after Western-blot hybridization, the patients were divided a negative and positive expression of H-Ras groups. RESULTS: Correlation analysis of methods used for determining the expression ability and concentration of H-Ras oncoproteins (immunohistochemistry and Western-blot analysis) demonstrated substantial statistical relationship Rs=0.71, p=0.03. The H-Ras oncoproteins were absent in patients receiving either "Arglabin" or standard AC regimen. However, in the AC + Arglabin group, there was a varying degrees of positive concentration of H-Ras oncoproteins (Kruskal-Wallis=6.92; p=0.03). CONCLUSION: These results indicate that Arglabin attenuates H-Ras oncoproteins expression which is a promising therapeutic target for breast cancer.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Terapia Neoadjuvante/métodos , Proteínas Proto-Oncogênicas p21(ras)/metabolismo , Neoplasias da Mama/metabolismo , Neoplasias da Mama/patologia , Ciclofosfamida/administração & dosagem , Doxorrubicina/administração & dosagem , Feminino , Seguimentos , Humanos , Prognóstico , Estudos Retrospectivos , Sesquiterpenos de Guaiano/administração & dosagem
2.
Appl Opt ; 50(28): F72-9, 2011 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-22016249

RESUMO

Noctilucent, or "night-shining," clouds (NLCs) are a spectacular optical nighttime phenomenon that is very often neglected in the context of atmospheric optics. This paper gives a brief overview of current understanding of NLCs by providing a simple physical picture of their formation, relevant observational characteristics, and scientific challenges of NLC research. Modern ground-based photographic NLC observations, carried out in the framework of automated digital camera networks around the globe, are outlined. In particular, the obtained results refer to studies of single quasi-stationary waves in the NLC field. These waves exhibit specific propagation properties--high localization, robustness, and long lifetime--that are the essential requisites of solitary waves.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...